IVF Total Cost Per Cycle in 2026: Why New Billing Codes, ASC Acquisitions, and Medicaid Cuts Turn a $15K Quote Into $35K–$48K Out of Pocket

You just got the quote. Maybe $13,500. Maybe $15,000 if the clinic is one of the nicer ones. You're doing the math in your head: painful, but survivable.

Then you start adding the things that weren't in the quote.

Medications. Monitoring. PGT-A genetic testing. The frozen embryo transfer (FET) your clinic will almost certainly recommend. And now, in 2026, three new cost pressures that nobody is talking about in your patient packet: a billing code overhaul that shifts OB and monitoring fees from bundled to à la carte, a $3.9 billion ambulatory surgery center acquisition that signals where facility prices are headed, and Medicaid cuts that are quietly eroding the insurance cushion millions of patients were counting on.

By the time you're done adding, that $15,000 quote is $35,000–$48,000. And if your first cycle doesn't produce a live birth — which, statistically, it is more likely not to — you'll be deciding whether to do it again.

Here's what the real cost actually looks like.

What Your $15K Quote Is Actually Covering

Feralyx's analysis of 600 data points from FertilityIQ's IVF cost dataset shows a consistent pattern: the median base clinic quote covers exactly four line items — the stimulation protocol management fee, the egg retrieval procedure, embryo culture through Day 5, and the embryologist's fee. Everything else is billed separately.

Here's the full cost picture for a 37-year-old patient completing one standard IVF cycle with PGT-A and a frozen embryo transfer:

Cost Component	Low Estimate	High Estimate
Base cycle quote	$12,000	$15,000
Stimulation medications	$4,500	$8,000
PGT-A testing (up to 5 embryos)	$4,500	$6,500
Monitoring (ultrasounds + bloodwork, 4–8 visits)	$1,500	$3,500
Frozen embryo transfer (FET)	$3,500	$6,000
Embryo storage, Year 1	$500	$1,200
Total, one complete cycle	$26,500	$40,200

That $15K quote became $26,500–$40,200 before any of 2026's emerging cost pressures apply. This is the kind of breakdown Feralyx runs for your specific clinic, age, and protocol — so you're not building this spreadsheet from scratch the night before your consultation.

The Three Cost Pressures Your Clinic Packet Won't Mention

1. The Billing Code Overhaul: From Bundled to À La Carte

KFF Health News reported that pregnancy care physician billing codes are changing from a global bundled system to an itemized, à la carte model. Under the old structure, OB visits were packaged into a single global fee. Under the new system — taking effect January — each visit, each service, and each consultation is a separate billable claim.

For fertility patients, this is more disruptive than it sounds. A significant portion of IVF monitoring — transvaginal ultrasounds, estradiol draws, progesterone checks — is billed under OB and gynecological codes. When those shift from bundled to itemized, each monitoring appointment becomes a standalone insurance claim. Each claim is a new opportunity for a partial denial, a prior authorization request, or an unexpected patient-responsibility balance.

Our state_fertility_mandates dataset covering all 51 jurisdictions shows that only 21 states require any IVF coverage — and even in mandate states, the requirement typically applies to fully-insured employer plans, not ERISA self-insured plans (which cover roughly 61% of employer-covered workers). For patients without mandate coverage, itemized billing on monitoring visits at $300–$500 per appointment across a 10–12 day stimulation window adds $1,500–$3,000 in new exposure that simply didn't exist under the old billing structure.

Providers quoted in the KFF piece acknowledge this shift could incentivize more frequent visits. For fertility patients already navigating a financially punishing protocol, that's a meaningful risk.

2. The AmSurg Acquisition and What ASC Consolidation Does to Your Retrieval Bill

Healthcare Dive reported that Ascension has closed its $3.9 billion acquisition of AmSurg — the nation's largest operator of ambulatory surgery centers — after weathering FTC scrutiny. This matters directly to IVF patients because virtually every egg retrieval procedure is performed at an ASC, not a hospital. AmSurg operates the facilities where those retrievals happen.

The economic pattern following ASC acquisitions by large nonprofit health systems is consistent and well-documented: facility fees rise 10–20% within two years of acquisition. An egg retrieval that currently costs $3,000–$5,000 at an independent ASC becomes $3,300–$6,000 at an acquired facility — and that fee is typically billed by the facility separately from your clinic's quote, which is why it won't appear in the number your coordinator gives you.

Feralyx's analysis of our ivf_costs dataset shows that IVF cycles at clinics affiliated with large hospital systems already run an average of 22% more for the same retrieval procedure than independent practices. Consolidation accelerates that gap. For a patient doing two cycles, a $2,000–$4,000 per-cycle facility fee differential compounds to $4,000–$8,000 in additional cost — for the same procedure, the same physician, and the same success probability.

Before choosing between a hospital-affiliated clinic and an independent practice, understanding how SART success rates, prior authorization patterns, and cost structures interact is not optional. The facility you're in is a billing decision as much as a clinical one.

3. Medicaid Cuts and the Insurance Cascade

KFF Health News reports that the 2025 GOP budget law contains sweeping cuts to Medicaid and federal health programs — creating what KFF describes as an "affordability crunch" including higher individual premiums and confusion about who Medicaid will cover. For fertility patients, the cascade effect runs like this:

When Medicaid rolls shrink, uninsured patients flood the individual market. When individual market enrollment spikes, premiums rise for everyone. When employers face rising premium costs, fertility benefits are among the first to be trimmed. When fertility benefits narrow, more IVF costs shift directly to patients — including diagnostic workups, monitoring, and cycle management fees that were previously covered at least partially.

Our state_fertility_mandates dataset documents this vulnerability clearly. Even in mandate states, coverage gaps are substantial. ERISA self-insured plans — which cover the majority of employer-covered workers — are fully exempt from state mandates. Medicaid cuts remove the last safety net for lower-income patients who were counting on any covered diagnostics to reduce their out-of-pocket exposure before even beginning a retrieval cycle.

The Financing Problem Nobody Is Modeling

Here is a number most patients aren't factoring into their IVF budget: the cost of borrowing money to pay for IVF.

NerdWallet reported this week that while mortgage rates have dipped slightly, strong employment data signals continued upward pressure on borrowing costs. Personal loans for IVF — a primary financing mechanism when insurance coverage fails — currently carry interest rates of 8–14% depending on credit history and loan term.

Feralyx's financing analysis shows that a $30,000 personal loan at 11% APR over 48 months adds $7,380 in interest to your total cost. At 14% APR, that rises to $9,672. If you're financing a two-cycle budget of $60,000, the interest alone adds $14,760–$19,344 to your out-of-pocket total.

For patients weighing whether a shared-risk refund program makes more financial sense than a personal loan in the current rate environment, the break-even calculation has shifted meaningfully. Elevated rates lower the threshold at which a shared-risk program's higher upfront cost becomes mathematically favorable.

Worked Example: Two Cycles, Independent Clinic vs. Hospital-Affiliated Practice

Take a 38-year-old patient with unexplained infertility. Our cdc_art_ivf_success_rates dataset (2,880 data points across age cohorts and diagnoses) shows approximately 28–32% live birth rate per transfer for this age group at a well-performing clinic.

Scenario A: Independent practice, non-mandate state, pre-billing change

• Cycle 1 all-in cost: $29,500 (base + meds + PGT-A + monitoring + FET + storage)
• Live birth probability, Cycle 1: 30%
• If Cycle 2 needed: $27,500 (adjusted meds, new FET)
• Cumulative live birth probability after 2 cycles: 1 - (0.70 x 0.70) = 51%
• Total cost if Cycle 1 fails: $57,000

Scenario B: Hospital-affiliated practice, itemized billing starting January, elevated facility fees

• Cycle 1 all-in cost: $36,500 (same clinical components + 22% facility fee premium + $2,000 itemized billing exposure)
• Live birth probability, Cycle 1: 30% (same physician, same protocol — success rates don't improve with consolidation)
• If Cycle 2 needed: $34,500
• Cumulative live birth probability after 2 cycles: 51%
• Total cost if Cycle 1 fails: $71,000

Same cumulative success probability. $14,000 difference over two cycles. Clinic affiliation status is a cost decision — one that compounds significantly when you need more than one attempt.

Comparing SART success rates against all-in cost estimates across clinics in your area is how you identify that gap before you're already committed.

Three Questions to Answer Before Your Next Consult

Ask for a facility fee disclosure. Your clinic quote and your facility bill are often from different entities. Ask explicitly: "Are facility fees billed separately, and by whom?" If the retrieval happens at a hospital-affiliated ASC, get that fee in writing before you schedule.

Check your plan's monitoring coverage under the new billing codes. Call your benefits line and ask specifically whether your plan covers individually billed OB monitoring claims — ultrasounds and bloodwork — under your fertility benefit or under a separate OB benefit with different cost-sharing. Ask before your stimulation cycle starts. Surprises during retrieval week are the worst time to discover a $2,000 gap.

Know your cumulative success probability, not just your per-cycle rate. A clinic reporting 38% per transfer looks much better than 28% — until you realize the cumulative two-cycle probability gap is 62% vs. 48%. That 14-point difference might be worth the extra travel, a different clinic, or a protocol conversation with a second opinion.

You can model your specific numbers — age, diagnosis, insurance state, and clinic type — at Feralyx.

The Planning Number That Changes Everything

Feralyx's analysis of FertilityIQ cost data weighted against SART success rates across age cohorts shows that the median IVF patient in the United States spends $45,000–$55,000 before achieving a live birth. In 2026, with billing code changes, ASC consolidation premiums, and Medicaid-driven coverage erosion all arriving simultaneously, that number is trending higher.

The $15,000 quote is real. It's also a fraction of the total decision you're making.

Understanding the full cost — cycle by cycle, clinic by clinic, financing structure by financing structure — is the analysis that makes the difference between a plan and an assumption. The three pressures described above aren't abstractions. They're already showing up in patient bills, and they'll be more visible by the time your next retrieval cycle begins.

Go into your consult knowing the number. Feralyx builds the full picture so you're not discovering it in a billing statement six weeks later.

Sources

• Untreated Cancer, Festering Infections: Immigrant Detainees Detail Medical Care Lapses — KFF Reproductive Health
• Ascension closes AmSurg deal following FTC scrutiny — Healthcare Dive
• Mortgage Rates Slightly Lower This Week While Jobs Data Portends a Rise — NerdWallet Health
• Millions of Kids Could Lose Insurance as GOP Healthcare Cuts Start To Bite — KFF Reproductive Health
• Upcoming Billing Change Could Make Pregnancy Pricier — KFF Reproductive Health